Objectives: 1. Describe the potential weaknesses of CPOE systems relating to single doses of long acting medications 2. Recall what question to ask in order to build a mental picture of a patient prior to beginning order review

Objectives: 1. Describe level of evidence for phenobarbital in AWS 2. Recall the 2 general dosing strategies for phenobarbital in AWS

Objectives: 1. Describe the different routes of FMT instillation 2. Recall the reason metoclopramide is used for upper GI FMT

Objectives: 1. Describe the evidence behind high dose nitroglycerin 2. Recall the average number of boluses required to complete this therapy

Objectives: 1. Describe the reason to delay the first dose of iodine when treating thyroid storm 2. Recall the most common precipitating causes of myxedema coma

Objectives: 1. Describe the population the CDC opioid guideline is meant to cover 2. Recall the recommended starting MME doses for hydrocodone, tramadol, and oxycodone

Objectives: 1. Describe the evidence levels supporting the different options for salvage therapy 2. Recall the dose of daptomycin to use for salvage therapy

Objectives: 1. Describe the different dosing strategies for IV diltiazem for atrial fibrillation or flutter 2. Recall the time to onset of heart rate reduction for diltiazem

Objectives: 1. Describe the on and off label uses of oral fosfomycin 2. Recall how to obtain IV fosfomycin

Objectives: 1. Describe the 3 indications for catheter directed alteplase 2. Recall the considerations surrounding heparin infusion for a patient receiving catheter directed alteplase

Objectives: 1. Describe the 2 main considerations when selecting an alternative local anesthetic during a drug shortage 2. Recall which local anesthetics are in the ester subgroup vs amide subgroup

Objectives: 1. Describe why an O2 sat of more than 90% with a PO2 of more than 70 mmHg suggests methemoglobinemia 2. Recall the dose of methylene blue for methemoglobinemia